Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  American Express Company    AXP

AMERICAN EXPRESS COMPANY (AXP)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

American Express Company : Wall Street Fundamentals Releases New In-Depth Stock Reports on AXP, BIIB, PGE, TGT

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/13/2013 | 02:35pm CEST

U.S. markets declined for the third consecutive day Wednesday due to a falling dollar against the yen and growing concerns of future stimulus measures from the Federal Reserve. Market volatility in recent weeks can be attributed to comments made by Federal Reserve Chairman Ben Bernanke on May 22nd, stating that monetary stimulus could be scaled back if the labor market showed "real and sustainable progress." On Wednesday, the Dow Jones industrial average declined 126.79 points, while the S&P 500 fell 13.61 points. Here is how some companies in the S&P 500 reacted Wednesday:

American Express Company (NYSE: AXP) shares traded in the range of $74.68 to $77.00 Wednesday before settling to close at $74.72, a decrease of 2.35 percent. The stock appears to be facing resistance at $75.70 with some support at $69.79. The company offers an annual dividend of $0.92 per share, $0.26 quarterly, for a dividend yield of approximately 1.23 percent. Shares of American Express have gained approximately 30 percent in 2013.

More information on American Express and access to the free equity report can be found at:
www.WallStreetFundamentals.com/AXP

Biogen Idec Inc. (NASDAQ: BIIB) shares traded in the range of $204.12 to $218.90 Wednesday before settling to close at $206.55, a decrease of 7.39 percent. The stock appears to be facing some resistance at the $214.14 with some support at $206.25. On Wednesday, Citi analyst Yaron Werber downgraded the company?s rating to ?neutral? from ?buy?. Shares of Biogen Idec have gained approximately 41.0 percent in 2013.

More information on Biogen Idec and access to the free equity report can be found at:
www.WallStreetFundamentals.com/BIIB

Pfizer Inc. (NYSE: PFE) shares traded in the range of $28.40 to $28.96 Wednesday before settling to close at $28.43, flat for the day. The stock appears to be facing some resistance at $28.92 with support at $28.49. Teva Pharmaceuticals Industries Ltd. and Sun Pharmaceutical Industries Ltd. have recently agreed to pay Pfizer $2.15 billion dollars to settle a patent suit. Shares of Pfizer have gained approximately 13.4 percent in 2013.

More information on Pfizer and access to the free equity report can be found at:
www.WallStreetFundamentals.com/PFE

Target Corporation (NYSE: TGT) shares traded in the range of $69.12 to $70.65 Wednesday before settling to close at $69.43, a decrease of 0.81 percent. The stock appears to be facing stiff resistance at $69.66 with some support at $67.79. On Wednesday, the company increased its quarterly dividend 19.4 percent to $0.43 per share. Shares of Target have gained approximately 17.3 percent in 2013.

More information on Target and access to the free equity report can be found at:
www.WallStreetFundamentals.com/TGT

Wall Street Fundamentals offers our members a full range of investor services including in-depth equity reports on your favorite companies and timely market updates featuring the hottest stocks trending in the marketplace.

Activate your always free membership by signing up at www.WallStreetFundamentals.com today.

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Wall Street Fundamentals has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Wall Street Fundamentals
Website: www.WallStreetFundamentals.com
Email: [email protected]


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AMERICAN EXPRESS COMPANY
04/20AMERICAN EXPRESS : Panel talks about Native connections to animals
AQ
04/19AMERICAN EXPRESS : AmEx Profit Climbs As Cardholders Spend -- WSJ
DJ
04/19AmEx profit tops estimates as record splurge on rewards woos customers
RE
04/19AmEx profit tops estimates as record splurge on rewards woos customers
RE
04/18AMERICAN EXPRESS : Posts 31% Jump in First-Quarter Profit -- Update
DJ
04/18AMERICAN EXPRESS : Posts 31% Jump in First-Quarter Profit -- 2nd Update
DJ
04/18AMERICAN EXPRESS : 1Q profits rise 31 percent, helped by taxes
AQ
04/18AMERICAN EXPRESS : Posts 31% Jump in First-Quarter Profit
DJ
04/18Visa, Mastercard Talk About Cooperating in Online Shopping
DJ
04/18AMERICAN EXPRESS CO : Regulation FD Disclosure (form 8-K)
AQ
More news
News from SeekingAlpha
04/19FINANCIALS - TOP GAINERS / LOSERS AS : 00 pm (04/19/2018) 
04/19American Express Is Firing On All Cylinders 
04/19AmEx up 6% post-earnings as sell-side weighs in 
04/19Flattening Yield Curve, Trade Tensions, Kinder Morgan (Wall Street Breakfast .. 
04/19WALL STREET BREAKFAST : Rally In Commodities Helps Push Stocks Higher 
Financials ($)
Sales 2018 40 274 M
EBIT 2018 10 605 M
Net income 2018 6 188 M
Debt 2018 -
Yield 2018 1,41%
P/E ratio 2018 14,19
P/E ratio 2019 12,80
Capi. / Sales 2018 2,03x
Capi. / Sales 2019 1,90x
Capitalization 81 843 M
Chart AMERICAN EXPRESS COMPANY
Duration : Period :
American Express Company Technical Analysis Chart | AXP | US0258161092 | 4-Traders
Technical analysis trends AMERICAN EXPRESS COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 33
Average target price 107 $
Spread / Average Target 4,5%
EPS Revisions
Managers
NameTitle
Stephen J. Squeri Chairman & Chief Executive Officer
Jeffrey C. Campbell Chief Financial Officer & Executive Vice President
Marc D. Gordon Chief Information Officer & Executive VP
Upendra Mardikar VP-Security Strategy, Architecture & Engineering
Charlene Barshefsky Independent Director
Sector and Competitors